Microba Life Sciences Ltd (ASX: MAP) Share Price and News

Mr Rombola has over 30 years of corporate and financial experience in Australia, Asia and the United Kingdom. He spent 19 years in senior positions with Morgan Stanley and Deutsche Bank, including 7 years in the role of Managing Director. He is a member of risk committee.

Mr Frazer is a clinician scientist, trained as a clinical immunologist. He is a Professor at the University of Queensland and is the current Co-Chair of the Australian Medical research Advisory Board (AMRAB) which advises the Minister for Health on prioritizing spending from the Medical Research Future Fund (MRFF). He is recognized as co-inventor of the technology enabling Gardasil- the leading vaccine currently used worldwide to assist in the prevention of cervical cancer. He is chair of risk committee.

Dr Hyungtae Kim is an internationally experienced leader in the genomics field, having held the positions of Chief Executive Officer of Macrogen, Inc., (Macrogen) from 2008 to 2014 and Chief Executive Officer of Macrogen Europe from 2015 to 2017. Dr Kim is a Director of Macrogen, a genomics company listed on the Korean Securities Dealers Automated Quotations (KOSDAQ). Dr Kim is now a Director of the Gongwu Genome Information Foundation.

Mr Bund is a Director of Equipe Advisory accounting firm. Mr Bund has more than 25 years of experience in accounting and corporate finance and is a director of several private Australian companies. He is a member of Risk Committee.

Professor Tyson is a Professor of Microbial Genomics at The Queensland University of Technology and is the Director of the Centre for Microbiome Research. He published the first paper regarding the use of metagenomic-sequencing for assessing microbial communities. Professor Tyson is considered a world leading expert in microbial analysis with previous tenure at the University of California, Massachusetts Institute of Technology and the University of Queensland.

Mrs Fernley currently serves as the Chief Investment Officer (CIO) of Mason Stevens where she leads the asset management division of the firm. Prior to joining Mason Stevens, Mrs Fernley held roles as Head of Equities at J B Were Limited, Head of Research at Wilson HTM and Australian Equity Portfolio Manager at Colonial First State Global Asset Management. Mrs Fernley is also intimately involved in mentoring and supporting women in the financial services industry and ESG, regularly presenting to investment committees, boards, and management on the topics. She was recently appointed to the diversity committee of the NSW CFA Society.

-

-

-

-

-